Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?
Answer from: Radiation Oncologist at Community Practice
Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
If T1-T2 with ITCs, I would not recommend PMRT. If T3 with ITCs, I would discuss the pros/cons and favor if ER-. If T4, I would recommend.
Comments
Radiation Oncologist at Radiation Oncology Associates P.C.
Would the presence of ITCs in multiple sentinel no...
Radiation Oncologist at Allegheny Health Network, Pittsburgh
It would not. As Dr. @Sushil Beriwal noted, i...
Radiation Oncologist at Radiation Oncology Associates P.C.
Thank you.
3872
3877
3887
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
For those seeking reference data on the above question, here are a couple: Karam et al., PMID 24035330 Mittendorf et al., PMID 25488970
Sign in or Register to read more
9093
9088
10713
Related Questions
What is your preferred sequencing of adjuvant chemotherapy and PMRT for node + breast cancer?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
Should PMRT be offered for ypN0(i+) disease if only 1-2 nodes were removed in the post-chemotherapy SLNB and there is no plan for a completion AxLND?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
What evidence supports the use of high tangents for pN1mic breast cancer?
In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Do you recommend re-excision of a unifocal positive anterior margin at skin after lumpectomy in a patient with otherwise low risk breast cancer features?